Case Report
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 16, 2025; 13(20): 100169
Published online Jul 16, 2025. doi: 10.12998/wjcc.v13.i20.100169
Radiofrequency ablation of liver metastases in a patient with pancreatic cancer and long-term survival: A case report
Jin-Peng Yong, Xiao-Yan Mu, Chao-Feng Zhou, Ke-Ke Zhang, Jie-Qiong Gao, Zhi-Zhong Guo, Shi-Fan Zhou, Zhen Ma
Jin-Peng Yong, Chao-Feng Zhou, Ke-Ke Zhang, Jie-Qiong Gao, Zhi-Zhong Guo, Shi-Fan Zhou, Department of Oncology, The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, Henan Province, China
Xiao-Yan Mu, Department of Oncology, Longhua Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, Shanghai 20001, China
Zhen Ma, Department of Neurology, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, Henan Province, China
Zhen Ma, Department of Oncology, Henan Hospital of Traditional Chinese Medicine, Zhengzhou 450000, Henan Province, China
Co-first authors: Jin-Peng Yong and Xiao-Yan Mu.
Co-corresponding authors: Zhi-Zhong Guo and Shi-Fan Zhou.
Author contributions: Yong JP and Mu XY contribute equally to this study as co-first authors; Guo ZZ and Zhou SF contribute equally to this study as co-corresponding authors; Yong JP was responsible for data analysis and writing; Mu XY was responsible for writing-review & editing; Zhou CF was responsible for data curation; Zhang KK and Gao JQ were responsible for data curation; Zhou SF was responsible for project administration; Guo ZZ was responsible for oversight and leadership responsibility for planning and executing research activities, including mentorship external to the core team; Ma Z was responsible for visualization/data presentation.
Informed consent statement: Patient consent was obtained, patient privacy was protected under the patient authorization, and data related to the pancreatic cancer were made publicly available.
Conflict-of-interest statement: All the authors have approved this study, and there are no conflicts of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhi-Zhong Guo, Doctor, Chief Doctor, Full Professor, Department of Oncology, The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine, No. 6 Dongfeng Road, Jinshui District, Zhengzhou 450000, Henan Province, China. fangliao0525@163.com
Received: August 15, 2024
Revised: September 5, 2024
Accepted: March 6, 2025
Published online: July 16, 2025
Processing time: 236 Days and 17.9 Hours
Core Tip

Core Tip: Patients with pancreatic cancer liver metastases have a worse prognosis than locally advanced pancreatic cancer patients do, with a median survival of less than 6 months; however, patients are now surviving for more than 6 years after radiofrequency ablation.